跳至主要内容
临床试验/EUCTR2009-012808-11-DE
EUCTR2009-012808-11-DE进行中(未招募)不适用

An open label, single dose, pharmacokinetic study of oromucosal midazolam administered to children from 3 months to less than 18 years undergoing routine elective surgery - Midazolam PK

Therakind Limited0 个研究点目标入组 75 人开始时间: 2009年8月7日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Male or female aged from 3 months – <18years of age.
  • 2. Attending the hospital for routine elective surgery
  • 3. In the clinical opinion of the clinician in charge, the child requires midazolam for pre-medication treatment.
  • 4. Parent(s) or legal guardian in attendance.
  • 5. Parent(s)/legal guardian able and willing to provide written informed consent for the child to take part in the study.
  • 6. Where applicable, the child should assent to undergo blood sampling for pharmacokinetic purposes and to allow physiological measurements to be made.
  • 7. American Society of Anesthesiologists (ASA) classification of illness score of 2 or less
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Known allergy to benzodiazepine medications.
  • 2. Exposure to benzodiazepines (including midazolam) in the preceding 7 days.
  • 3. Exposure to drugs known to pharmacokinetically interact with midazolam in the preceding 7 days.
  • 4. Receiving any chronic medication, except inhaled asthma therapies. Patients that have received periodic simple analgesics such as paracetamol, ibuprofen etc will not be excluded.
  • 5. Participation in this or any clinical study in the previous 30 days or scheduled to receive any other investigational drug during the course of the study.
  • 6. Any clinically significant medical condition or abnormality, which, in the opinion of the investigator, might compromise the safety of the patient or which might interfere with the study.
  • 7. Females who are pregnant, lactating or planning to become pregnant.
  • 8. Patients with a known history of epilepsy

研究者

发起方
Therakind Limited

相似试验